FDA will review Eisai and Biogen’s Alzheimer’s treatment Leqembi with decision on full approval expected in early July

March 6, 2023 admin National Comments Off on FDA will review Eisai and Biogen’s Alzheimer’s treatment Leqembi with decision on full approval expected in early July

Visits: 0

Medicare has agreed to provide broader coverage once Leqembi receives full FDA approval. Read More Go To Source